IFNG and neoplasm: Specifically, IFN-γ inhibits CTL function by upregulating the expression of programmed death ligand 1 (PD-L1) on the surface of tumor cells; thus, increasing its binding to the programmed cell death-1 (PD-1) receptor on the surface of CTL cells (28).